Mastoid neoplasm: a clinical case
https://doi.org/10.25207/1608-6228-2021-28-2-135-143
Abstract
Background. Middle ear neoplasm is a rare pathology accounting for about 0.7% total head and neck tumours. The article describes the clinical presentation, diagnostic methods and surgical treatment for neoplasms of mastoid process, a quite rare tumour localisation.
Clinical Case Description. Patient G., 66 yo, was admitted to a otorhinolaryngological unit with a preliminary diagnosis of left mastoid neoplasm and complaints of non-transient headache on the left and slight hearing loss in both ears. The symptoms have been persisting since childhood. Laboratory tests without abnormalities. Voluminous invasive neoplasm of left temporal bone mastoid in CT. Left mastoidectomy with mastoid neoplasm resection was performed routinely, with a histological examination of surgical material. Benign angiofibroma in morbid histology. Definitive diagnosis: neoplasm of left mastoid. Relief from headache and overall improvement were reported by the patient in two months after surgery.
Conclusion. Benign mastoid angiofibroma is a rare tumour in terms of localisation and morphology reluctant to diagnosis in an asymptomatic form. We suggest computed tomography as the main diagnostic and surgery — as main treatment method in this pathology. The disease has a life-favourable prognosis.
About the Authors
F. V. Semenov
Kuban State Medical University; Territorial Hospital No. 3
Russian Federation
Russian Federation
Fedor V. Semenov — Dr. Sci. (Med.), Prof., Head of the Chair of Otorhinolaryngology; Chief Physician
Mitrofana Sedina str., 4, Krasnodar, 350063
Zakharova str., 59, Krasnodar, 350007
R. V. Reznikov
Kuban State Medical University; Territorial Hospital No. 3
Russian Federation
Russian Federation
Roman R. Reznikov — Research Assistant, Chair of Otorhinolaryngology; Physician (otorhinolaryngology)
Mitrofana Sedina str., 4, Krasnodar, 350063
Zakharova str., 59, Krasnodar, 350007
A. A. Strelyaev
Kuban State Medical University
Russian Federation
Russian Federation
Artem A. Strelyaev — Clinical Resident, Chair of Otorhinolaryngology
Mitrofana Sedina str., 4, Krasnodar, 350063
+7 (989) 292-97-97
References
1. Jia X., Liang Q., Chi F. Treatment and outcome of middle ear cancer. Eur. Arch. Otorhinolaryngol. 2014; 271(10): 26750–26780. DOI: 10.1007/s00405-013-2728-1
2. Wierzbicka M., Niemczyk K., Bruzgielewicz A., Durko M., Klatka J., Kopeć T., Osuch-Wójcikiewicz E., Pietruszewska W., Szymański M., Szyfter W. Multicenter experiences in temporal bone cancer surgery based on 89 cases. PLoS One. 2017; 12(2): e0169399. DOI: 10.1371/journal.pone.0169399
3. Blackburn P.R., Carter J.M., Oglesbee D., Westendorf J.J., Neff B.A., Stichel D., Tsen D.W., Gavrilova R.H., Wesseling P., von Deimling A., Caulfield T.R., Klee E.W., Pusch S., Inwards C.Y. An activating germline IDH1 variant associated with a tumor entity characterized by unilateral and bilateral chondrosarcoma of the mastoid. Human Genetics and Genomics Advances. 2020; 1(1): 100006. DOI: 10.1016/j.xhgg.2020.100006
4. Frisch C.D., Inwards C.Y., Lalich I.J., Carter J.M., Neff B.A. Atypical cartilaginous tumor/chondrosarcoma, grade 1, of the mastoid in three family members: A new entity. Laryngoscope. 2016; 126(9): E310–Е313. DOI: 10.1002/lary.25802
5. Zhao E.E., Liu Y.F., Oyer S.L., Smith M.T., McRackan T.R. Chondrosarcoma arising in the mastoid involving the intratemporal facial nerve. JAMA Otolaryngol. Head Neck Surg. 2019; 145(4): 392–393. DOI: 10.1001/jamaoto.2018.4149
6. Shen W., Sakamoto N., Yang L. Prognostic models to predict overall and cause-specific survival for patients with middle ear cancer: a population-based analysis. BMC Cancer. 2014; 14: 554. DOI: 10.1186/1471-2407-14-554
7. Koto M., Hasegawa A., Takagi R., Sasahara G., Ikawa H., Mizoe J.E., Jingu K., Tsujii H., Kamada T., Okamoto Y; Organizing Committee for the Working Group for Head and Neck Cancer. Carbon ion radiotherapy for locally advanced squamous cell carcinoma of the external auditory canal and middle ear. Head Neck. 2016; 38(4): 512–516. DOI: 10.1002/hed.23905
8. Leong S.C., Youssef A., Lesser T.H. Squamous cell carcinoma of the temporal bone: outcomes of radical surgery and postoperative radiotherapy. Laryngoscope. 2013; 123(10): 2442–2448. DOI: 10.1002/lary.24063
9. Rodgers B., Bhalla V., Zhang D., El Atrouni W., Wang F., Sundararajan J., Lin J. Bilateral inflammatory myofibroblastic tumor mastoiditis. Head Neck. 2015; 37(11): E142–Е145. DOI: 10.1002/hed.23978
10. Wallis S., Atkinson H., Coatesworth A.P. Chronic otitis media. Postgrad. Med. 2015; 127(4): 391–395. DOI: 10.1080/00325481.2015.1027133
11. Kynion R. Mastoiditis. Pediatr. Rev. 2018; 39(5): 267–269. DOI: 10.1542/pir.2017-0128
12. Zanoletti E., Franz L., Cazzador D., Franchella S., Calvanese L., Nicolai P., Mazzoni A., Marioni G. Temporal bone carcinoma: novel prognostic score based on clinical and histological features. Head Neck. 2020; 42(12): 3693–3701. DOI: 10.1002/hed.26435
13. Gupta R., Sandison A., Wenig B.M., Thompson L.D.R. Data set for the reporting of ear and temporal bone tumors: explanations and recommendations of the guidelines from the international collaboration on cancer reporting. Arch. Pathol. Lab. Med. 2019; 143(5): 593–602. DOI: 10.5858/arpa.2018-0415-SA
14. Castro M, Goycoolea M, Galvez M, Silva V, Montoya C, Fuentes J. Mastoid osteoma in a prehispanic cranium (1390 A.D.) from Northern Chile. Int. J. Paleopathol. 2019; 24: 141–143. DOI: 10.1016/j.ijpp.2018.10.006
15. Zhang J., Tingting H., Jin Y., Xianmin W., Li H., Xiaoyun C. A rare case of adenoid cystic carcinoma isolated in the mastoid. J. Int. Adv. Otol. 2019; 15(1): 177–180. DOI: 10.5152/iao.2019.6036
Supplementary files
Review
For citations:
Semenov F.V., Reznikov R.V., Strelyaev A.A. Mastoid neoplasm: a clinical case. Kuban Scientific Medical Bulletin. 2021;28(2):135-143. (In Russ.) https://doi.org/10.25207/1608-6228-2021-28-2-135-143
Views:
1126
Email this article 